BackClinuvel Pharmaceuticals Overview
Clinuvel Pharmaceuticals Ltd.

Clinuvel Pharmaceuticals Return on Equity

Latest ROE for Clinuvel Pharmaceuticals: 28.59% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

28.59%

Return on Equity

28.59%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Clinuvel Pharmaceuticals (CUVL) FAQ

Clinuvel Pharmaceuticals (CUVL) currently reports a ROE of 28.59%. That is above the Healthcare sector average of 13.1%. Use the charts on this page to explore Clinuvel Pharmaceuticals's ROE history and peer comparisons.

Clinuvel Pharmaceuticals's ROE of 28.59% is higher than the Healthcare sector average of 13.1%. That is roughly 118.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Clinuvel Pharmaceuticals's current 28.59% should be judged against Healthcare norms (sector average: 13.1%) and against CUVL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 28.59%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.1%. From there, open related valuation or income-statement pages for Clinuvel Pharmaceuticals, and consider following CUVL for alerts when major investors trade the stock.

Clinuvel Pharmaceuticals is classified in the Healthcare sector. On ROE, it currently shows 28.59% versus a sector average near 13.1%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CUVL with unrelated industries.

Questions & Answers